Speaking of pandemics..
作者信息
Schechter Michael S
机构信息
Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Virginia Commonwealth University, Children's Hospital of Richmond at VCU, 1000 East Broad Street, P.O. Box 980315, Richmond, VA 23298-0315, United States.
出版信息
J Cyst Fibros. 2021 Jul;20(4):564-565. doi: 10.1016/j.jcf.2021.04.017. Epub 2021 Jun 5.
Abstract
摘要
相似文献
1
Speaking of pandemics..说到大流行病……
J Cyst Fibros. 2021 Jul;20(4):564-565. doi: 10.1016/j.jcf.2021.04.017. Epub 2021 Jun 5.
2
Cystic Fibrosis Transmembrane Conductance Regulator. Implications in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.囊性纤维化跨膜传导调节因子。在囊性纤维化和慢性阻塞性肺疾病中的意义。
Ann Am Thorac Soc. 2016 Apr;13 Suppl 2:S150-5. doi: 10.1513/AnnalsATS.201509-588KV.
3
Cystic fibrosis transmembrane conductance regulator modulators: Present and future in cystic fibrosis treatment. A review.囊性纤维化跨膜传导调节因子调节剂：囊性纤维化治疗的现状与未来。综述
Arch Argent Pediatr. 2019 Apr 1;117(2):e131-e136. doi: 10.5546/aap.2019.eng.e131.
4
A current review of the safety of cystic fibrosis transmembrane conductance regulator modulators.当前对囊性纤维化跨膜电导调节剂调节剂安全性的综述。
J Clin Pharm Ther. 2021 Apr;46(2):286-294. doi: 10.1111/jcpt.13329. Epub 2020 Dec 7.
5
The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis.囊性纤维化跨膜电导调节因子调节剂在囊性纤维化中的肺外作用。
Ann Am Thorac Soc. 2020 Feb;17(2):147-154. doi: 10.1513/AnnalsATS.201909-671CME.
6
Optimising the care and quality of life of people with cystic fibrosis: the influence of cystic fibrosis transmembrane conductance regulator modulators.优化囊性纤维化患者的护理和生活质量：囊性纤维化跨膜电导调节剂的影响。
Br J Hosp Med (Lond). 2021 Nov 2;82(11):1-6. doi: 10.12968/hmed.2021.0530. Epub 2021 Nov 22.
7
How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease?囊性纤维化跨膜传导调节因子突变如何导致肺部疾病？
Curr Opin Pulm Med. 1995 Nov;1(6):435-43. doi: 10.1097/00063198-199511000-00002.
8
Novel, mechanism-based therapies for cystic fibrosis.针对囊性纤维化的新型、基于机制的疗法。
Curr Opin Pediatr. 2005 Jun;17(3):385-92. doi: 10.1097/01.mop.0000158846.95469.6f.
9
Cystic fibrosis transmembrane conductance-regulator modulators for children.用于儿童的囊性纤维化跨膜传导调节因子调节剂
Lancet Respir Med. 2017 Jul;5(7):536-537. doi: 10.1016/S2213-2600(17)30208-4. Epub 2017 Jun 9.
10
The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.囊性纤维化跨膜传导调节因子增效剂依伐卡托增强黏液纤毛清除功能，消除香烟烟雾对囊性纤维化跨膜传导调节因子的抑制作用。
Am J Respir Cell Mol Biol. 2017 Jan;56(1):99-108. doi: 10.1165/rcmb.2016-0226OC.
引用本文的文献
1
Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.囊性纤维化患者呼吸系统健康的社会经济决定因素：对治疗策略的影响。
Expert Rev Respir Med. 2022 Jun;16(6):637-650. doi: 10.1080/17476348.2022.2090928. Epub 2022 Jun 23.
本文引用的文献
1
Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry data.停止吸烟暴露可改善儿童 CF 结局：CF 基金会患者登记数据的纵向分析。
J Cyst Fibros. 2021 Jul;20(4):618-624. doi: 10.1016/j.jcf.2021.06.014. Epub 2021 Jul 17.
2
Social Inequities and Cystic Fibrosis Outcomes: We Can Do Better.社会不平等与囊性纤维化的治疗结果：我们可以做得更好。
Ann Am Thorac Soc. 2021 Feb;18(2):215-217. doi: 10.1513/AnnalsATS.202010-1274ED.
3
Tobacco Product Use Among Adults - United States, 2019.成年人烟草制品使用情况 - 美国，2019 年。
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742. doi: 10.15585/mmwr.mm6946a4.
4
Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis.烟草烟雾暴露限制了泰它西普/依伐卡托在儿科囊性纤维化患者中的治疗获益。
J Cyst Fibros. 2021 Jul;20(4):612-617. doi: 10.1016/j.jcf.2020.09.011. Epub 2020 Oct 3.
5
Integration of mental health screening and treatment into cystic fibrosis clinics: Evaluation of initial implementation in 84 programs across the United States.将心理健康筛查和治疗纳入囊性纤维化诊所：在美国 84 个项目中初步实施情况的评估。
Pediatr Pulmonol. 2020 Nov;55(11):2995-3004. doi: 10.1002/ppul.24949. Epub 2020 Jul 21.
6
Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation.儿童囊性纤维化中的烟草烟雾暴露：临床医生和照护者对戒烟看法的定性研究。
Pediatr Pulmonol. 2020 Sep;55(9):2330-2340. doi: 10.1002/ppul.24879. Epub 2020 Jun 8.
7
Who Smokes in Europe? Data From 12 European Countries in the TackSHS Survey (2017-2018).谁在欧洲吸烟？ TackSHS 调查（2017-2018 年）中 12 个欧洲国家的数据。
J Epidemiol. 2021 Feb 5;31(2):145-151. doi: 10.2188/jea.JE20190344. Epub 2020 Apr 4.
8
Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis.烟草烟雾暴露和社会经济因素是儿童囊性纤维化肺部下降的独立预测因素。
J Cyst Fibros. 2020 Sep;19(5):783-790. doi: 10.1016/j.jcf.2020.02.004. Epub 2020 Feb 17.
9
Treating Parents for Tobacco Use in the Pediatric Setting: The Clinical Effort Against Secondhand Smoke Exposure Cluster Randomized Clinical Trial.在儿科环境中治疗父母吸烟行为：预防二手烟暴露的临床努力集群随机临床试验
JAMA Pediatr. 2019 Oct 1;173(10):931-939. doi: 10.1001/jamapediatrics.2019.2639.
10
Protecting Young Children From Tobacco Smoke Exposure: A Pilot Study of Project Zero Exposure.保护幼儿免受烟草烟雾暴露：零暴露项目的初步研究。
Pediatrics. 2018 Jan;141(Suppl 1):S107-S117. doi: 10.1542/peds.2017-1026N.
Zotero 插件